Skip to content

The effect of hyperferritinemia on microvascular complications in patients with Type 2 diabetes: a prospective cohort study

The effect of hyperferritinemia on microvascular disease in patients with Type 2 diabetes: a prospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021180
Enrollment
Unknown
Registered
2019-02-01
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

iron overload

Interventions

Case series:No

Sponsors

Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Long-term residence of Tibetan plateau; 2. Diagnosed as type 2 diabetes, aged from 18-80 years old.

Exclusion criteria

Exclusion criteria: 1. Diagnosed as diabetic retinopathy already; 2. Diagnosed as acute or chronic kidney disease; 3. Blood systerm disease (including anemia and myelodysplastic Syndrom),subjects who need blood transfusion or with a history of blood transfusion in recently three months; 4. A History of bleeding or surgery; 5. Subjests with ALT=3X and other live disease, such as hepatitis, alcoholic liver disease and liver cirrhosis; 6. Other serious disease, such as heart failure, renal failure and cancer; 7. Acute and chronic inflammation, autoimmune disease, CRP >10.0mg/L; 8. Acute stress state; 9. Expectation of life is less than 2 years; 10. Serious mental illness.

Design outcomes

Primary

MeasureTime frame
serum feriitin;serum creatinine;Urinary albumin/urinary creatinine;

Countries

China

Contacts

Public ContactZhang Chenghui

Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region

657038252@qq.com+86 13551368629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026